Annual Working Capital
$137.97 M
+$32.98 M+31.42%
31 December 2023
Summary:
UroGen Pharma annual working capital is currently $137.97 million, with the most recent change of +$32.98 million (+31.42%) on 31 December 2023. During the last 3 years, it has risen by +$43.79 million (+46.50%). URGN annual working capital is now at all-time high.URGN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$262.31 M
+$17.57 M+7.18%
30 September 2024
Summary:
UroGen Pharma quarterly working capital is currently $262.31 million, with the most recent change of +$17.57 million (+7.18%) on 30 September 2024. Over the past year, it has increased by +$105.97 million (+67.79%). URGN quarterly working capital is now at all-time high.URGN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
URGN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.4% | +67.8% |
| 3 y3 years | +46.5% | +149.0% |
| 5 y5 years | +55.4% | +79.9% |
URGN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +50.0% | at high | +380.7% |
| 5 y | 5 years | at high | +55.4% | at high | +380.7% |
| alltime | all time | at high | +716.7% | at high | +1287.6% |
UroGen Pharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $262.31 M(+7.2%) |
| June 2024 | - | $244.75 M(+43.6%) |
| Mar 2024 | - | $170.42 M(+23.5%) |
| Dec 2023 | $137.97 M(+31.4%) | $137.97 M(-11.7%) |
| Sept 2023 | - | $156.34 M(+186.5%) |
| June 2023 | - | $54.57 M(-22.9%) |
| Mar 2023 | - | $70.74 M(-32.6%) |
| Dec 2022 | $104.99 M(+14.1%) | $104.99 M(+2.3%) |
| Sept 2022 | - | $102.59 M(-15.6%) |
| June 2022 | - | $121.58 M(-14.0%) |
| Mar 2022 | - | $141.43 M(+53.7%) |
| Dec 2021 | $92.01 M(-2.3%) | $92.01 M(-12.6%) |
| Sept 2021 | - | $105.33 M(-13.3%) |
| June 2021 | - | $121.44 M(+59.6%) |
| Mar 2021 | - | $76.08 M(-19.2%) |
| Dec 2020 | $94.18 M | $94.18 M(-15.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $111.72 M(-1.6%) |
| June 2020 | - | $113.52 M(+5.4%) |
| Mar 2020 | - | $107.66 M(-16.6%) |
| Dec 2019 | $129.15 M(+45.5%) | $129.15 M(-11.4%) |
| Sept 2019 | - | $145.79 M(-18.7%) |
| June 2019 | - | $179.35 M(-24.6%) |
| Mar 2019 | - | $238.02 M(+168.1%) |
| Dec 2018 | $88.78 M(+31.6%) | $88.78 M(-13.4%) |
| Sept 2018 | - | $102.50 M(-9.1%) |
| June 2018 | - | $112.75 M(-8.5%) |
| Mar 2018 | - | $123.20 M(+82.7%) |
| Dec 2017 | $67.44 M(+256.7%) | $67.44 M(-10.7%) |
| Sept 2017 | - | $75.52 M(+3.0%) |
| June 2017 | - | $73.34 M(+287.9%) |
| Dec 2016 | $18.90 M(+11.9%) | $18.90 M |
| Dec 2015 | $16.89 M | - |
FAQ
- What is UroGen Pharma annual working capital?
- What is the all time high annual working capital for UroGen Pharma?
- What is UroGen Pharma annual working capital year-on-year change?
- What is UroGen Pharma quarterly working capital?
- What is the all time high quarterly working capital for UroGen Pharma?
- What is UroGen Pharma quarterly working capital year-on-year change?
What is UroGen Pharma annual working capital?
The current annual working capital of URGN is $137.97 M
What is the all time high annual working capital for UroGen Pharma?
UroGen Pharma all-time high annual working capital is $137.97 M
What is UroGen Pharma annual working capital year-on-year change?
Over the past year, URGN annual working capital has changed by +$32.98 M (+31.42%)
What is UroGen Pharma quarterly working capital?
The current quarterly working capital of URGN is $262.31 M
What is the all time high quarterly working capital for UroGen Pharma?
UroGen Pharma all-time high quarterly working capital is $262.31 M
What is UroGen Pharma quarterly working capital year-on-year change?
Over the past year, URGN quarterly working capital has changed by +$105.97 M (+67.79%)